Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NYSTATIN vs OBINUTUZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NYSTATIN vs OBINUTUZUMAB: Safety Overview

Metric NYSTATIN OBINUTUZUMAB
Total FAERS Reports 1,892 14,189
Deaths Reported 179 1,919
Death Rate 9.5% 13.5%
Hospitalizations 457 5,419
Average Patient Age 55.9 yrs 63.8 yrs
% Female Patients 67.2% 41.7%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Crown Laboratories Genentech, Inc.
Route TOPICAL INTRAVENOUS
Marketing Status Discontinued Prescription